Considering previous reports on the correlation between JMJD6 and cancers, as well as the link between inflammation and cancers, we conducted further investigations using serum samples from patients with esophageal cancer (EC), gastric cancer (GC), lung cancer (LC), and mammary cancer (MC) (Table 5, upper panel). Here, JMJD6 is linked to laryngotracheoesophageal cleft.